Abatacept ttCTLA4ConjugateAbciximab ttGPIIAIIIBAdalimumab ttTNFalphaAIN457Alemtuzumab ttCD52AMG386 ttAngiopoietin1 ttAngiopoietin2Antibodies (bispecific)Antibodies (therapeutic use)AscitesAtacicept ttBlys ttAPRILBapineuzumab ttAmyloidBetaBasiliximab ttIL2RBelatacept ttCD80 ttCD86Belimumab ttBLySBevacizumab ttVEGFBi20 ttCD20Blinatumomab ttCD19Brentuximab vedotin ttCD30Briakinumab ttIL12 ttIL23
Canakinumab ttIL1betaCatumaxomab ttEpCAM ttCD3 linkerAbCertolizumab ttTNFalphaCetuximab ttEGFRDaclizumab ttIL2RDalotuzumab ttIGF1RDenosumab ttRANKLEculizumab ttFactorHEfalizumab ttLFA1Epratuzumab ttCD22Ertumaxomab ttHER2Etanercept ttTNFalphaFactorIXFc ttFactorIXFactorVIIIFc ttFactorVIIIFarletuzumab ttFolateRalphaGemtuzumab ozogamicin ttCD33Girentuximab ttCarbonicAnhydraseIXGolimumab ttTNFalphaIbritumomab tiuxentan yttrium ttCD20
Infliximab ttTNFalphaIpilimumab ttCTLA4Motavizumab ttRSVirusMuromonabCD3 ttCD3Naptumomab estafenatox tt5T4Natalizumab ttIntegrinalpha4Necitumumab ttEGFRNimotuzumab ttEGFRObinutuzumab ttCD20Ofatumumab ttCD20Omalizumab ttCD20Otelixizumab ttCD3Pagibaximab ttLipoteichoicAcidStaphlococcusPalivizumab ttRSVirusFproteinPanitumomab ttEGFRPeritoneum (Carcinomatosis)Pertuzumab ttHER2Ramucirumab ttVEGFR2Ranibizumab ttVEGF
Raxibacumab ttAnthraxREGN88 ttIL6RReslizumab ttIL5Rilonacept ttIL1RRituximab ttCD20Solanezumab ttAmyloidBetaStomach (Neoplasia)T1H ttCD6Teplizumab ttCD3Tocilizumab ttIL6Tositumomab ttCD20Trastuzumab emtansine ttHER2Trastuzumab ttHER2Tremelimumab ttCLTA4Ustekinumab ttIL12 ttIL23Vedolizumab ttIntegrina4b7Zalutumumab ttEGFRZanulimumab ttCD4
Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth
All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.